Do not use Apidra® during a low blood sugar reaction (hypoglycemia)
or if you are allergic to any of the ingredients in Apidra®.
You must test your blood sugar levels while using insulin, such as Apidra®.
Do not make any changes to your dose or type of insulin without talking to your
healthcare provider. Any change of insulin should be made cautiously and only under
medical supervision. Apidra® must only be used if the solution is
clear and colorless with no particles visible. Do not share needles, insulin
pens or syringes with others.
Apidra®, when given by injection under the skin, should not be mixed
with insulins other than NPH. Do not mix Apidra® with any insulin
when used in the pump or for intravenous administration.
The most common side effect of insulin, including Apidra®, is
low blood sugar (hypoglycemia), which may be serious. Some people may
experience symptoms such as shaking, sweating, fast heartbeat, and blurred vision.
Severe hypoglycemia can be dangerous and can cause harm to your heart or brain.
It may cause unconsciousness, seizures, or death. Other possible side effects may
include low blood potassium, injection site reactions, such as changes in fat tissue
at the injection site, and allergic reactions, such as itching and rash. Less common,
but potentially more serious or life-threatening, is generalized allergy to insulin,
including anaphylactic reactions.
Tell your doctor about other medicines and supplements you are taking because they
can change the way insulin works. Before starting Apidra®, tell your
doctor about all your medical conditions including if you have liver or kidney problems,
are pregnant or planning to become pregnant, or are breast-feeding or planning to
breast-feed.
If the pump or infusion set does not work right, you may not receive the right amount
of insulin. Hypoglycemia, hyperglycemia, or ketosis can happen. Problems should
be identified and corrected as quickly as possible. Change the Apidra®
in the pump reservoir every 48 hours.
Indications and Usage
Prescription Apidra® is for adults with type 2 diabetes or adults
and children (4 years and older) with type 1 diabetes to improve blood sugar control.
Apidra® is usually used with a longer-acting insulin. When used as
a mealtime insulin, Apidra® should be given within 15 minutes before
or within 20 minutes after starting a meal.
Apidra® may be infused subcutaneously by external insulin infusion
pumps.
Apidra® SoloSTAR® is a disposable prefilled insulin
pen.
Click
here for additional important information for Apidra®.
